MYLAN LABORATORIES LIMITED R&D CENTER

Company Introduction: MYLAN LABORATORIES LIMITED R&D CENTER

MYLAN LABORATORIES LIMITED R&D CENTER is the research and development arm of Mylan Laboratories Limited, a global pharmaceutical company. Its primary function is to conduct research, develop new drug formulations, improve existing products, and innovate pharmaceutical processes. This center is crucial for the company's growth and competitive edge in the pharmaceutical industry, focusing on scientific discovery and product development rather than direct manufacturing or trading.

Classification:

It is neither a factory nor a trader. It is a research and development facility. While Mylan Laboratories Limited as a whole is a pharmaceutical manufacturer, the R&D Center's specific role is innovation and development, supporting the manufacturing operations of the parent company.

Mylan Laboratories Limited R&D Center in India contributes to the development of a diverse portfolio of pharmaceutical products that are subsequently manufactured and sold globally by Mylan, and now by Viatris following their merger. The products primarily encompass:

Generic Pharmaceuticals:

A vast range of generic medications across numerous therapeutic areas. This includes treatments for cardiovascular diseases, central nervous system disorders, oncology, pain and inflammation, infectious diseases (including antiretrovirals for HIV/AIDS), respiratory conditions, gastrointestinal disorders, and women's health issues.

Biosimilar Products:

Development and production of biosimilars, which are highly similar biological products to existing approved reference medicines, particularly in areas like oncology and immunology.

Specialty Pharmaceuticals:

A selection of specialized pharmaceutical products often targeting complex or chronic conditions.

Over-the-Counter (OTC) Products:

Various non-prescription drugs available directly to consumers.

The R&D center's work is integral to developing new formulations, improving existing products, and ensuring the quality and efficacy of these pharmaceutical offerings across a wide spectrum of medical needs.